Sustained Response to Vemurafenib in a BRAF-Mutated Anaplastic Thyroid Carcinoma Patient.

Thyroid 2016 10 27;26(10):1515-1516. Epub 2016 Sep 27.

1 Department of Medicine I, Comprehensive Cancer Center Vienna; Medical University of Vienna , Vienna, Austria .

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2015.0575DOI Listing
October 2016
9 Reads

Publication Analysis

Top Keywords

vemurafenib braf-mutated
4
thyroid carcinoma
4
braf-mutated anaplastic
4
anaplastic thyroid
4
response vemurafenib
4
sustained response
4
carcinoma patient
4
carcinoma
1
patient
1
anaplastic
1
vemurafenib
1
braf-mutated
1
sustained
1
thyroid
1

Similar Publications